October 30, 2024 02:10 PM EDT

AbbVie’s immunology blockbusters make up for Humira sales drop in Q3

Katherine Lewin

News Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Regeneron plans to buy 23andMe for $256M

David Liu, Sam Sternberg unveil new way to insert big genes in human cells

Prime Medicine sidelines only clinical program, replaces CEO and lays off some staff

Exclusive: CellCentric collects $120M to treat multiple myeloma with a capsule

Apnimed posts first set of Phase 3 sleep apnea results, aims for approval filing in 2026

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?